Super Micro faces increased competitive pressures, losing 300 bp of market share, with Nvidia increasingly shifting its partnership to Foxconn, impacting Super Micro's outlook. Financial concerns ...
Super Micro Computer stock is gaining ground ahead of a business update conference the company has scheduled for tomorrow. The conference could include preliminary Q2 results and information about ...
If there is a pistol category that has been a driver of development and innovation in recent years, it’s been the micro 9mm handguns, which are 9mm pistols smaller than what we would traditionally ...
A micro-cap stock is a stock with a total market capitalization between $300 million and $2 billion. These stocks are often smaller, less established operations. But these companies have limitless ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.
Whatever the form, these Windows micro desktops all deliver surprising features, value, and pep for their size. I have been a technology journalist for 30-plus years and have covered just about ...
Vu Technologies was founded as a high-end electronics company in 2006 by Devita Saraf, who became its CEO and Design Head. With a sales turnover of ₹1 billion, the company turned profitable in 2012.
Vu Technologies was founded as a high-end electronics company in 2006 by Devita Saraf, who became its CEO and Design Head. With a sales turnover of ₹1 billion, the company turned profitable in 2012.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results